0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prenylflavonoids isolated from Epimedii Herba show inhibition activity against advanced glycation end-products

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction: As inhibitors of advanced glycation end products (AGEs), such as pyridoxamine, significantly inhibit the development of retinopathy and neuropathy in rats with streptozotocin-induced diabetes, treatment with AGE inhibitors is believed to be a potential strategy for the prevention of aging, age-related diseases, and lifestyle-related diseases, including diabetic complications. In the present study, the MeOH extract of Epimedii Herba (EH; aerial parts of Epimedium spp.) was found to inhibit the formation of N ε -(carboxymethyl)lysine (CML) and N ω -(carboxymethyl) arginine (CMA) during the incubation of collagen-derived gelatin with ribose.

          Materials and methods: EH was purchased from Uchida Wakan-yaku Co., and a MeOH extract was prepared. Several steps of column chromatography purified the extract. Each fraction was tested for inhibitory activity by ELISA using monoclonal antibodies for CML and CMA.

          Results: After activity-guided fractionation and purification by column chromatography, three new prenylflavonoids [named Koreanoside L ( 1), Koreanoside E1 ( 2), and Koreanoside E2 ( 3)] and 40 known compounds ( 443) were isolated from EH, and their inhibitory effects against CML and CMA formation were tested. Among these, epimedokoreanin B ( 8), epimedonin E ( 21), epicornunin B ( 22), and epicornunin F ( 24) inhibited the formation of both CML and CMA, with epimedokoreanin B ( 8) having the most potent inhibitory effect among the isolated compounds. To obtain the structure–activity relationships of 8, the phenolic hydroxy groups of 8 were methylated by trimethylsilyl-diazomethane to afford the partially and completely methylated compounds of 8. Prenyl derivatives of propolis (artepillin C, baccharin, and drupanin) were used in the assay.

          Discussion: As only 8 showed significant activity among these compounds, the catechol group of the B ring and the two prenyl groups attached to the flavanone skeleton were essential for activity. These data suggest that 8 could prevent the clinical complications of diabetes and age-related diseases by inhibiting AGEs.

          Related collections

          Most cited references51

          • Record: found
          • Abstract: not found
          • Article: not found

          High-field FT NMR application of Mosher's method. The absolute configurations of marine terpenoids

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

            N(epsilon)-(Carboxymethyl)lysine (CML), a major product of oxidative modification of glycated proteins, has been suggested to represent a general marker of oxidative stress and long-term damage to proteins in aging, atherosclerosis, and diabetes. To investigate the occurrence and distribution of CML in humans an antiserum specifically recognizing protein-bound CML was generated. The oxidative formation of CML from glycated proteins was reduced by lipoic acid, aminoguanidine, superoxide dismutase, catalase, and particularly vitamin E and desferrioxamine. Immunolocalization of CML in skin, lung, heart, kidney, intestine, intervertebral discs, and particularly in arteries provided evidence for an age-dependent increase in CML accumulation in distinct locations, and acceleration of this process in diabetes. Intense staining of the arterial wall and particularly the elastic membrane was found. High levels of CML modification were observed within atherosclerotic plaques and in foam cells. The preferential location of CML immunoreactivity in lesions may indicate the contribution of glycoxidation to the processes occurring in diabetes and aging. Additionally, we found increased CML content in serum proteins in diabetic patients. The strong dependence of CML formation on oxidative conditions together with the increased occurrence of CML in diabetic serum and tissue proteins suggest a role for CML as endogenous biomarker for oxidative damage.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Advanced glycation end products in the pathogenesis of chronic kidney disease.

              Advanced glycation end products (AGEs) are stable posttranslational modifications of proteins formed by the spontaneous reaction with glucose and related metabolites. Important AGEs quantitatively are methylglyoxal (MG)-derived hydroimidazolone MG-H1, Nε-carboxymethyl-lysine (CML), and glucosepane. They contribute to the development of chronic kidney disease (CKD). Cellular proteolysis of AGE-modified proteins forms AGE free adducts, glycated amino acids, which are cleared by the kidneys and excreted in urine. Dietary AGEs mainly supplement the endogenous flux of AGE free adduct formation. AGE free adducts accumulate markedly in plasma with decline in glomerular filtration rate. A key precursor of AGEs is the dicarbonyl metabolite MG, which is metabolized by glyoxalase 1 (Glo1) of the cytoplasmic glyoxalase system. Proteins susceptible to MG modification are collectively called the dicarbonyl proteome. Abnormal increase of MG dicarbonyl stress is a characteristic of CKD, driven by down-regulation of renal Glo1, increasing flux of MG-H1 formation. Protein inactivation and dysfunction linked to the dicarbonyl proteome contributes to CKD development. The receptor for AGEs, RAGE, is important in development of CKD, but its interaction with AGEs in vivo remains enigmatic; other ligands and ternary complexation may be influential. Prevention of diabetic kidney disease (DKD) by overexpression of Glo1 in transgenic animal models has stimulated the development of small-molecule inducers of Glo1 expression, Glo1 inducers, to prevent AGE formation. trans-Resveratrol-hesperetin combination therapy is a Glo1 inducer. In clinical trial it demonstrated a profound improvement in insulin resistance and vascular inflammation. It may find future therapeutic application for treatment of DKD.
                Bookmark

                Author and article information

                Contributors
                URI : https://loop.frontiersin.org/people/2704135/overviewRole: Role: Role: Role: Role: Role: Role: Role:
                Role: Role: Role: Role: Role: Role:
                Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/795113/overviewRole: Role: Role: Role: Role: Role:
                Role: Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/838690/overviewRole: Role: Role: Role: Role: Role: Role: Role: Role: Role: Role:
                Journal
                Front Chem
                Front Chem
                Front. Chem.
                Frontiers in Chemistry
                Frontiers Media S.A.
                2296-2646
                31 May 2024
                2024
                : 12
                : 1407934
                Affiliations
                [1] 1 Faculty of Pharmaceutical Sciences , Sojo University , Kumamoto, Japan
                [2] 2 Department of Cell Pathology , Graduate School of Medical Sciences , Faculty of Life Sciences , Kumamoto University , Kumamoto, Japan
                [3] 3 Department of Food and Life Science , School of Agriculture , Tokai University , Kumamoto, Japan
                Author notes

                Edited by: Bun Chan, Nagasaki University, Japan

                Reviewed by: Aizhamal Baiseitova, Gyeongsang National University, Republic of Korea

                Bing Chen, Fujian Medical University, China

                *Correspondence: Tsuyoshi Ikeda, tikeda@ 123456ph.sojo-u.ac.jp
                Article
                1407934
                10.3389/fchem.2024.1407934
                11176478
                38882216
                0ac29a70-e628-493d-8d97-b05961407783
                Copyright © 2024 Nakashima, Miyashita, Yoshimitsu, Fujiwara, Nagai and Ikeda.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 27 March 2024
                : 07 May 2024
                Funding
                The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by JSPS KAKENHI, Grant Numbers 20K07122 to TI and 22K20730 to KN.
                Categories
                Chemistry
                Original Research
                Custom metadata
                Medicinal and Pharmaceutical Chemistry

                epimedii herba,prenylflavonoid,advanced glycation end products,n ε -(carboxymethyl)lysine,n ω -(carboxymethyl) arginine

                Comments

                Comment on this article